Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02122809
Title Phase I Study of Chiauranib in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Chipscreen Biosciences, Ltd.
Indications

Advanced Solid Tumor

ovarian cancer

renal cell carcinoma

gastrointestinal stromal tumor

lung non-small cell carcinoma

stomach cancer

colorectal cancer

Therapies

Chiauranib

Age Groups: adult
Covered Countries

Facility Status City State Zip Country Details
Cancer Hospital, Chinese Academy of Medical Sciences Beijing Beijing 100021 China Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field